atopic-dermatitis

Documents about atopic-dermatitis

• Evaluation of the Efficacy of a Dermocosmetic Product RT00401-GO0046 on Atopic Dermititis Severity in Subjects With Mild Atopic Dermatitis Versus Placebo#905264ClinicalTrials.gov
• Long-Term Safety Follow-Up Study of SCM-AGH in Subjects Who Participated and Administered SCM-AGH in to Severe Atopic Dermatitis Clinical Trials#826596ClinicalTrials.gov
• An Observational Study of Upadacitinib to Assess Change in Disease Activity in Canadian Adult Participants With Moderate-to-Severe Atopic Dermatitis Who Are Inadequate Responders To or Discontinuing Dupilumab#912318ClinicalTrials.gov
• Efficacy of Crisaborole 2% Cream Versus Placebo in Mild to Moderate Atopic Eczema#905753ClinicalTrials.gov
• Efficacy of Fermented Rice Flour for the Treatment of Atopic Dermatitis: Randomized, Double-blind Controlled Trial#180421ClinicalTrials.gov
• Safety and Efficacy Study of Q301 in Mild to Moderate Adolescents and Adults Atopic Dermatitis Patients#802955ClinicalTrials.gov
• Safety and Efficacy Study of Topically Applied DS107 Cream in Mild to Moderate Atopic Dermatitis Patients (AD)#804397ClinicalTrials.gov
• B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic Dermatitis#806631ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of AK120 in Subjects With Moderate to Severe Atopic Dermatitis#828654ClinicalTrials.gov
• A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitis#851753ClinicalTrials.gov
• Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation#851792ClinicalTrials.gov
• Ruxolitinib Cream in Participants With Facial and/or Neck Atopic Dermatitis Involvement#853949ClinicalTrials.gov
• The Efficacy of 3% Kanuka Oil Versus 1% Hydrocortisone Cream in Patients With Atopic Dermatitis#859241ClinicalTrials.gov
• Multiple Rising Dose Study of MK-6194 in Participants With Atopic Dermatitis (MK-6194-008)#887521ClinicalTrials.gov
• Clinic-Based Atopic Dermatitis Therapeutic Patient Education#890979ClinicalTrials.gov
• A Study to Evaluate the Safety and Efficacy of AK120 in Subjects With Moderate to Severe Atopic Dermatitis#895460ClinicalTrials.gov
• Investigation of Topical SB705498 on Healthy Volunteers#909582ClinicalTrials.gov
• Asthma, Missed Immunizations, and Vitamin D Deficiency in Atopic Dermatitis#912485ClinicalTrials.gov
• Exploratory Study to Evaluate the Application of NLAC Cream in Adults With Atopic Dermatitis#969334ClinicalTrials.gov
• Efficacy and Safety of a a Biofunctional Textile in the Management of Atopic Dermatitis#978907ClinicalTrials.gov
• Topically Applied AMTX-100 CF for Adult Patients With Mild to Moderate Atopic Dermatitis#1007413ClinicalTrials.gov
• Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older#910143ClinicalTrials.gov
• Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic Dermatitis#870504ClinicalTrials.gov
• Analysis of the Quality of Life, the Clinical Effectiveness and Cost-effectiveness of a Novel Educational Programme in Patients With Psoriasis and Atopic Dermatitis#913362ClinicalTrials.gov
• Paediatric atopic eczema (atopic dermatitis) in South Africa : a practical algorithm for the management of mild-to-moderate disease in daily clinical practice#637727SUNScholar
• The Efficacy of Patients With Moderate to Severe Atopic Dermatitis Treated With Chinese Herbal Medicine#829110ClinicalTrials.gov
• IDA (Immunothérapie de la Dermatite Atopique) Adult - Immunotherapy in Atopic Dermatitis#226359ClinicalTrials.gov
• Efficacy of Combining Topical Antibiotic/Steroid/Moisturizer Therapy Compared to Active Comparator in Atopic Dermatitis.#633741ClinicalTrials.gov
• Registry for the Atopic Dermatitis Research Network#808002ClinicalTrials.gov
• The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic Dermatitis#884200ClinicalTrials.gov
• Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic Dermatitis#891815ClinicalTrials.gov
• The Study of CM326 in Patients With Moderate-to-severe Atopic Dermatitis#918437ClinicalTrials.gov
• Does Timeliness of DTaP-IPV-Hib Vaccination Affect Development of Atopic Dermatitis Before 1 Year of Age?#803783ClinicalTrials.gov
• Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects#837382ClinicalTrials.gov
• Effect of Benralizumab in Atopic Dermatitis#968725ClinicalTrials.gov
• A Study to Assess the Safety, Tolerability, PK and PD of AM1030-CREAM in Patients With Atopic Dermatitis#861142ClinicalTrials.gov
• Nutritional Study to Determine the Effect of Fish Oil on Atopic Dermatitis#861978ClinicalTrials.gov
• Safety and Bioequivalence of Pimecrolimus Cream 1% and Elidel R in Treatment of Mild to Moderate Atopic Dermatitis#880008ClinicalTrials.gov
• Validation of the Short-term Antimicrobial Action of Transplanted Bacteria#881531ClinicalTrials.gov
• Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to Severe Atopic Dermatitis#884945ClinicalTrials.gov
• Safety Study of Tezepelumab (AMG 157) in Healthy Adults and Adults With Atopic Dermatitis#888749ClinicalTrials.gov
• A Study of EDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis#891454ClinicalTrials.gov
• Study to Evaluate the Use of RHT-3201 in SCORAD Reduction in Young Patients With Atopic Dermatitis#907643ClinicalTrials.gov
• Influence of disease control and perceived risk on atopic dermatitis treatment decisions.#140929PubMed
• Vitamin D and Its Receptor Gene Polymorphisms in Lithuanian, Latvian and Taiwanese Patients With Atopic Dermatitis and Asthma#471483ClinicalTrials.gov
• Study in Healthy Participants and Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasis, and/or Mild Asthma#803759ClinicalTrials.gov
• Involvement of Pollutants in Atopic Dermatitis and Psoriasis#825326ClinicalTrials.gov
• Clinical Study of Trilinolein Cream for Prevention of Relapse in Remission of Moderate-to-severe Atopic Dermatitis.#828049ClinicalTrials.gov
• Study of the Safety, Tolerability and Efficacy of BTX 1204 in Patients With Moderate Atopic Dermatitis#839020ClinicalTrials.gov
• A Clinical Study of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis#842270ClinicalTrials.gov